Alecensa (Alectinib)
- Drug Name: Alecensa
- Generic Name: Alectinib
- Dosage Forms and Strengths: It is available as Capsules in 150 mg
- Manufactured by: Genentech
ALECENSA, a kinase inhibitor, is prescribed for patients diagnosed with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) detected by an FDA-approved test, offering targeted treatment for this specific cancer subtype.
Recommended Dosage:
Administer ALECENSA orally at a dosage of 600 mg twice daily, with food.
- Monitor liver function tests every 2 weeks for the initial 3 months of treatment with ALECENSA, then monthly and as needed, especially in patients experiencing liver enzyme or bilirubin elevations. In case of severe elevations, temporarily stop, adjust dosage, or discontinue treatment.
- Immediately pause ALECENSA if interstitial lung disease (ILD) or pneumonitis is diagnosed, discontinuing permanently if no alternative cause is found.
- For severe renal impairment, temporarily halt ALECENSA, resuming at a lower dose upon recovery or permanently discontinuing.
- Regularly monitor heart rate and blood pressure; if symptomatic bradycardia occurs, pause ALECENSA, adjust dosage, or stop treatment.
- Assess creatine phosphokinase (CPK) levels every 2 weeks initially and in patients reporting unexplained muscle symptoms; temporarily pause, resume at a lower dose, or discontinue ALECENSA for severe CPK elevations.
- ALECENSA may cause fetal harm; advise females of reproductive age to use effective contraception and discuss the potential risks to a fetus.
If you are considering the import of Alecensa (Alectinib) capsules to India, please be aware that Alecensa can be imported by patients or government hospitals solely in the name of the patients. The following documentation is essential for the successful import of this medication:
Required Documentation for Import:
- A valid prescription from a qualified medical practitioner.
- Diagnostic reports of the patient.
- Government-issued identification proof for the patient, as recognized by the Government of India.
Order Confirmation Process:
The order for Alecensa (Alectinib) will be confirmed upon the receipt of the following documents:
- A valid prescription from a qualified doctor.
- An import permit, if applicable.
Alectinib can be made accessible to patients, doctors, and hospitals in various cities across India, including but not limited to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune. To confirm an order, a valid prescription from a doctor and an import permit will be required.
Our commitment lies in assuring quality and timely delivery to meet the healthcare needs of patients and medical professionals across the globe.
Indian Pharma Network is proficient in sourcing Alectinib from around the world and ensuring efficient delivery to patients. We provide worldwide access to the best available treatments and expedite prescription dispensing and delivery, with all prescriptions being dispensed and scrutinized by registered pharmacists before dispatching them to the patient’s address, exclusively from New Delhi, India.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.